NEUROFIBROMATOSIS (NONMALIGNANT)

Clinical trials for NEUROFIBROMATOSIS (NONMALIGNANT) explained in plain language.

Never miss a new study

Get alerted when new NEUROFIBROMATOSIS (NONMALIGNANT) trials appear

Sign up with your email to follow new studies for NEUROFIBROMATOSIS (NONMALIGNANT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Mapping the mystery: 5-Year study tracks NF1 skin tumors with 3D cameras

Knowledge-focused Ongoing

This study aims to understand how and why benign skin tumors grow in people with Neurofibromatosis Type 1 (NF1). Researchers at Johns Hopkins will follow 500 participants for five years, using annual 3D whole-body imaging to track changes in these tumors over time. The goal is to…

Matched conditions: NEUROFIBROMATOSIS (NONMALIGNANT)

Sponsor: Johns Hopkins University • Aim: Knowledge-focused

Last updated Mar 27, 2026 12:39 UTC

NEUROFIBROMATOSIS (NONMALIGNANT)

Get alerted when new NEUROFIBROMATOSIS (NONMALIGNANT) trials appear

Mapping the mystery: 5-Year study tracks NF1 skin tumors with 3D cameras